[Muscular contraction and metabolic conditions].

P. Kissel,J. Schmitt,M. Duc,M. Duc

1965-12-01

Abstract:

What problem does this paper attempt to address?

Early Outcomes of Robotic Versus Thoracoscopic Segmentectomy for Early-Stage Lung Cancer: A Multi-Institutional Propensity Score-Matched Analysis

Yajie Zhang,Chun Chen,Jian Hu,Yu Han,Maosheng Huang,Jie Xiang,Hecheng Li

DOI: https://doi.org/10.1016/j.jtcvs.2019.12.112

2020-01-01

Abstract:Objectives: Anatomical segmentectomy via robotic thoracic surgery and video-assisted thoracic surgery (VATS) are minimally invasive surgical approaches for treatment of early-stage non-small cell lung cancer (NSCLC). However, few research studies have compared early outcomes. Methods: A retrospective analysis was made of 774 patients, 298 who received robotic and 476 who received VATS, who underwent minimally invasive segmentectomy for early-stage NSCLC at 3 academic institutions between June 2015 and August 2019. Perioperative outcomes were compared after propensity score-matching on the basis of age, gender, body mass index, percent forced expiratory volume in I second, smoking status, American Society of Anesthesiologists score, type of segmentectomy, tumor size, and institution. Results: There were 257 patients in each group after propensity score-matching. The baseline characteristics and type of segmentectomy were comparable. Three conversions to thoracotomy occurred in the VATS group, and 1 in the robotic group (P = .624). There was no significant difference in operative time (147.91 +/- 52.42 vs 149.23 +/- 49.66 minutes; P = .773), blood loss (50 mL [interquartile range (IQR), 50-100 mL] vs 100 mL [IQR, 30-100 mL]; P = .177), rates of overall complications (17.9 vs 14.8%; P = .340), and length of stay (4 days [IQR, 3-5 days] vs 4 days [IQR, 3-5 days]; P = .417) between the robotic and VATS groups, respectively. Robotic segmentectomy was more costly ($12,019.30 +/- 1678.30 vs $7834.80 +/- 1291.20; P < .001) because of the amortization and consumables of the robotic system. There were a greater number of N1 lymph nodes and N1 stations in the robotic group. Conclusions: Segmentectomy with robotic and VATS are safe and feasible for early-stage NSCLC treatment. A robotic approach might lead to a better N1 lymph node dissection.
Comparison of Robotic and Video-Assisted Thoracic Surgery for Lung Cancer: a Propensity-Matched Analysis.

Feichao Bao,Chong Zhang,Yunhai Yang,Zhehao He,Luming Wang,Jian Hu

DOI: https://doi.org/10.21037/jtd.2016.05.99

2016-01-01

Journal of Thoracic Disease

Abstract:BACKGROUND:Reports of comparison between robotic and thoracoscopic surgery for lung cancer are limited, we aimed to compare the perioperative outcomes of robotic and thoracoscopic anatomic pulmonary resection for lung cancer.METHODS:A total of 184 patients with lung cancer underwent anatomic pulmonary resection by robotics or thoracoscopy. A propensity-matched analysis with incorporated preoperative variables was used to compare the perioperative outcomes between the two procedures.RESULTS:Overall, 71 patients underwent robotic pulmonary resection, including 64 lobectomies and 7 segmentectomies, while 113 patients underwent thoracoscopic lobectomy and segmentectomy. Propensity match produced 69 pairs. The mean length of postoperative stay (7.6±4.6 vs. 6.4±2.6 d, P=0.078), chest tube duration (5.3±3.7 vs. 4.4±1.7 d, P=0.056), number of lymph nodes retrieved (17.9±6.9 vs. 17.4±7.0, P=0.660), stations of lymph nodes resected (7.4±1.6 vs. 7.6±1.7, P=0.563), operative blood loss (53.9±29.3 vs. 50.3±37.9 mL, P=0.531), morbidity rates (42.0% vs. 30.4%, P=0.157) were similar between the robotics and thoracoscopy. However, robotics was associated with higher cost ($12,067±1,610 vs. $8,328±1,004, P<0.001), and longer operative time (136±40 vs. 111±28 min, P<0.001).CONCLUSIONS:Robotics seems to have higher hospital costs and longer operative time, without superior advantages in morbidity rates and oncologic efficiency. Further prospective randomized clinical trials were needed to validate both of its short- and long-term oncologic efficiency.
Perioperative Comparison of Video-Assisted Thoracic Surgery and Open Lobectomy for Pt1-Stage Non-Small Cell Lung Cancer Patients in China: a Multi-Center Propensity Score-Matched Analysis.

Jinming Xu,Heng Ni,Yihe Wu,Jinlin Cao,Xingpeng Han,Lunxu Liu,Xiangning Fu,Yin Li,Xiaofei Li,Lin Xu,Yang Liu,Heng Zhao,Deruo Liu,Xin Peng,Jian Hu

DOI: https://doi.org/10.21037/tlcr-20-1132

2021-01-01

Translational Lung Cancer Research

Abstract:BACKGROUND:Compared with open surgery, video-assisted thoracic surgery (VATS) has innovated the concept of the minimally invasive approach for non-small cell lung cancer (NSCLC) patients in past decades. This present study aimed to compare the perioperative and lymph node dissection outcomes between VATS lobectomy and open lobectomy for pathological stage T1 (pT1) NSCLC patients from both surgical and oncologic perspectives.METHODS:This was a retrospective multicenter study. Patients who underwent surgical resection for pT1 NSCLC between January 2014 and September 2017 were retrospectively reviewed from 10 thoracic surgery centers in China. Perioperative and lymph node dissection outcomes of pT1 NSCLC patients who accepted VATS or open lobectomies were compared by propensity score matching (PSM) analysis.RESULTS:Of the 11,360 patients who underwent surgery for pT1 NSCLC, 7,726 were enrolled based on the selection criteria, including 1,222 cases of open lobectomies and 6,504 cases of VATS lobectomies. PSM resulted in 1,184 cases of open lobectomies and 1,184 cases of VATS lobectomies being well matched by common prognostic variables, including age, sex, and surgical side. VATS lobectomy led to better perioperative outcomes, including less blood loss (133.5±200.1 vs. 233.3±318.4, P<0.001), lower blood transfusion rate (2.4% vs. 6.4%, P<0.001), shorter postoperative hospital stay (8.6±5.7 vs. 10.1±5.1, P<0.001), less chest drainage volume (1,109.5±854.0 vs. 1,324.1±948.8, P<0.001), and less postoperative complications (4.9% vs. 8.2%, P<0.001). However, open lobectomy had better lymph node dissection outcomes than VATS, with increased lymph node dissection numbers (16.1±9.4 vs. 13.7±7.7, P<0.001) and more positive lymph nodes being dissected (1.5±3.9 vs. 1.1±2.5, P=0.002). Compared with VATS, open lobectomy harvested more lymph node stations (5.5±1.9 vs. 5.2±1.8, P=0.001), including more pathological N2 (pN2) lymph node stations (3.4±1.4 vs. 3.1±1.3, P<0.001).CONCLUSIONS:VATS lobectomy was associated with better perioperative outcomes, such as less blood loss, lower blood transfusion rate, shorter postoperative hospital stay, less chest drainage volume and less postoperative complications. Open lobectomy has improved lymph node dissection outcomes, as more lymph nodes and positive lymph nodes were dissected for pT1 NSCLC patients during surgery.
Comparing the Efficacy of Video-Assisted Thoracoscopic Surgery and Open Thoracotomy in Sleeve Lobectomy for the Treatment of Central-Type Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Hua Cai,Canhua Huang,Hui-Chun Wu,Yihua Wu,Zhiyuan Huang,Shan Su,C H Li

2024-01-01

Abstract:Central-type Non-small Cell Lung Cancer (NSCLC) treatment involves different surgical techniques, including Video-Assisted Thoracoscopic Surgery (VATS) and Open Thoracotomy Sleeve Lobectomy. However, there remains a lack of consensus on the most effective treatment modality.This study strictly adhered to PRISMA guidelines. Four electronic databases were searched without time or language limitation, and studies comparing VATS and Open Thoracotomy in patients with central-type NSCLC undergoing sleeve lobectomy were included. Primary outcomes were perioperative outcomes (blood loss, operation time, intraoperative lymph node dissection count, postoperative hospital stay, and complication rates), 3-year Progression-Free Survival (PFS) rate, and Overall Survival (OS) rate.The meta-analysis included six studies with 569 patients. VATS was associated with longer operation time [SMD = 0.75, 95% CI (0.29, 1.21)], less intraoperative blood loss [SMD = -0.23; 95% CI (-0.44, -0.01)], and shorter hospital stay [SMD = -0.53; 95% CI (-0.73, -0.34)]. There were no significant differences in the number of lymph nodes dissected, postoperative complications, and 3-year PFS and OS rates between the two groups.VATS sleeve lobectomy for central-type NSCLC results in less surgical trauma and quicker postoperative recovery without adversely impacting tumor prognosis compared to open thoracotomy sleeve lobectomy. Despite a longer operation time, VATS could be considered an alternative to open thoracotomy sleeve lobectomy. VATS sleeve lobectomy is a safe and effective alternative to open thoracotomy in treating central-type NSCLC, as it results in less surgical trauma and quicker postoperative recovery without impacting tumor prognosis negatively. More well-designed randomized controlled trials are required to verify these findings.
[Short-term and long-term survival in sleeve lobectomy by video-assisted thoracic surgery versus thoracotomy basing on the propensity score matching]

M J Pan,H J Gao,Z H Jiang,D Wang,K Liu,Y C Wei

DOI: https://doi.org/10.3760/cma.j.issn.0529-5815.2018.07.010

2018-07-01

Abstract:Objective: To evaluate the safety and efficacy of patients with centrally located lung cancer in sleeve lobectomy by video-assisted thoracic surgery (VATS). Methods: A retrospective analysis was performed on consecutive patients with centrally located lung cancer who underwent sleeve lobectomy admitted in the Affiliated Hospital of Qingdao University from January 2010 to September 2014. Propensity score matching analysis was performed to compare patients for thoracoscopic surgery and open surgery. Twenty-one pairs (42 cases) patients were included for analysis. The t-test, χ(2) test or Fisher's exact probabilities was adopted, if appropriate, to compare demographics and outcomes between the 2 groups. The Kaplan-Meier method and the Log-rank test were used for the distributions of disease free survival (DFS) and overall survival (OS) and their comparisons. Results: After propensity score-matched analysis, the VATS group had a longer operative time ((296.9±73.6) minutes vs. (218.1±59.2) minutes, t=3.82, P=0.00), but shorter postoperative drainage time ((3.3±1.5) days vs. (2.0±3.0) days, t=-0.93, P=0.01) and hospitalization time((6.7±2.8) days vs. (12.1±8.7)days, t=-1.72, P=0.01) than that of the thoracotomy group. Perioperative complications, 1-year and 3-year disease-free and overall survival rates were not statistically different between the two groups. Conclusion: For suitable patients, sleeve lobectomy by VATS is an acceptable safe and effective surgical procedure for patients with central lung cancer.
Comparison of Sleeve Lobectomy for Lung Cancer Using Mini-Thoracotomy and an Optimized Robot-Assisted Technique

Tao Shaolin,Feng Yonggeng,Kang Poming,Mei Longyong,Shen Cheng,Fang Chunshu,Wu Licheng,Tan Qunyou,Deng Bo

DOI: https://doi.org/10.1177/15330338211051547

Abstract:Objective: To evaluate the clinical significance of an optimized approach to improve surgical field visualization and simplify anastomosis techniques using robotic-assisted sleeve lobectomy for lung or bronchial carcinoma. Method: A total of 26 consecutive patients who underwent sleeve lobectomy between January 2017 and April 2020 were enrolled in the study. The cohort included 11 cases of robotic-assisted surgery (RAS group) and 15 cases of mini-thoracotomy (MT group). RAS was performed via an exclusive optimized approach utilizing the "3 to 4-6 to 8/9" four-port technique. Retrieved demographical and clinical data included operation time, anastomosis time, blood loss, chest drainage time and volume, postoperative pain scores, complications, white blood cell (WBC) levels, and duration of hospital stay and follow-up. Results: No cases of perioperative death were recorded. Compared to MT group, the RAS group had a similar anastomosis time (30.82 ± 6.08 vs 33.20 ± 7.73 min, respectively, p > 0.05) and shorter operation time (189.73 ± 36.41 vs 225.33 ± 38.19 min, respectively, p < 0.05). The RAS group had lower pain scores (4.23 ± 0.26 vs 4.91 ± 0.51, p < 0.05), lower levels of WBC (p < 0.05), and no anastomotic complications postoperatively. The RAS and MT groups demonstrated a successful bronchus reconstruction with low risk of angulation (1/11 vs 1/15, p > 0.05) and satisfactory disease-free survival (eight cases, 72.73% and 12 cases, 80%, respectively). Conclusion: The optimized approach to RA sleeve lobectomy is convenient and efficient and provides satisfactory clinical outcomes. Further study with a large sample size and evaluation of long-term survival are warranted. Key points: (i) we present a novel, convenient, and efficient approach for robotic-assisted sleeve lobectomy, ie, "3 to 4-6 to 8/9" four-port technique. The optimized approach for RA sleeve lobectomy is convenient and efficient and provides satisfactory clinical outcomes; (ii) details for the "3 to 4-6 to 8/9" four-port method: the assistant port was located at the fourth intercostal space. The 1-cm camera port was inserted at the sixth intercostal space in the posterior axillary line. The 0.5-cm da Vinci ports of the instrument arms were placed at the third intercostal space in the anterior axillary line and the eighth or ninth intercostal space in the posterior axillary line. The patient cart was inserted from the back of the patient's head and shoulders at 75° to the longitudinal line.
Initial Experience of Robotic Sleeve Resection for Lung Cancer Patients

Xufeng Pan,Chang Gu,Rui Wang,Heng Zhao,Jianxin Shi,Haiquan Chen

DOI: https://doi.org/10.1016/j.athoracsur.2016.06.054

IF: 5.113

2016-01-01

The Annals of Thoracic Surgery

Abstract:Background. The purpose of this study was to identify the technical aspects and short-term results of robotic sleeve resection for lung cancer patients.Methods. Twenty-one consecutive cases of robotic sleeve resection from September 2014 to September 2015 were reviewed.Results. There were 17 single sleeve resection (bronchial) and4 double sleeve resection(bronchial andvascular) cases. Nineteen of 21 cases (90.5%) achieved R0 resection. The mean console time was 120.4 +/- 37.3 minutes. Themean operation time was 158.4 +/- 42.0 minutes. There was no massive bleeding (800 mL or more) during operation. The mean intraoperative blood loss was 157.1 +/- 97.8 mL. One case (4.8%) was converted to thoracotomy owing to severe calcification of lymph node. There was no intraoperative death. The overall complication rate was 19.0%. The major complications were subcutaneous emphysema (14.4%), cardiac arrhythmia (9.6%), pneumonia (9.6%), pyothorax (9.6%), bronchial anastomosis bleeding (4.8%), bronchial anastomosis leakage (4.8%), and multiple organ failure (4.8%). The 30-day mortality rate was 4.8%. The mean postoperative length of stay was 10.7 +/- 7.6 days.Conclusions. Robotic sleeve resection is technically feasible and can be carried out with acceptable short-term results. (C) 2016 by The Society of Thoracic Surgeons
Comparison of long-term survival between robotic and video-assisted lobectomy for stage I NSCLC with radiologic solid tumors:A Propensity Score Matching Study

Jianfeng Zhang,Zhongjie Wang,Yuming Wang,Xuewen Yu,Yanpen Liang,Changbo Sun,Qianjun Zhou

DOI: https://doi.org/10.1016/j.cllc.2024.10.004

IF: 4.84

2024-10-30

Clinical Lung Cancer

Abstract:Background To compare the long-term survival between robotic and video-assisted thoracic surgery (VATS) lobectomy for stage I non-small cell lung cancer (NSCLC) with radiologic solid tumors. Methods Clinical stage I NSCLC patients with radiologic solid tumors who underwent robotic-assisted thoracic surgery (RATS) or VATS lobectomy between 2015 and 2017 were retrospectively reviewed. A propensity score matching analysis was performed to balance the baseline characteristics. The primary end points were overall survival (OS) and recurrence-free survival (RFS). Results A total of 518 patients (225 RATS and 293 VATS) were included. After propensity score matching, there were 170 cases in each group. Patients undergoing RATS had shorter operative time than VATS (98.12 min vs. 112.26 min; p < 0.001). The RATS approach resulted in a higher number of resected lymph nodes (LNs) (11.75 vs 9.77; p < 0.001). The postoperative complication rates were comparable (7.6% vs. 10.0%, p, 0.566). The rates of 5-year OS and RFS for the RATS and VATS were 92% vs.89% (p, 0.62) and 82% vs. 86% (p, 0.70), respectively. Multivariate analysis revealed that the number of resected LNs was significantly associated with overall survival (OR=1.94 [95% confidence interval [CI]: 1.07-3.51], p, 0.029). Conclusion The long-term survival outcomes of RATS and VATS are similar for c-stage I NSCLC with radiologic solid tumors. The use of robotics is associated with more lymph node dissection and shorter operative time. We suggested that the number of examined lymph nodes rather than surgical approaches was associated with overall survival. Micro The safety and efficacy of video-assisted thoracic surgical (VATS) versus robotic lobectomy for solid non-small cell lung cancer (NSCLC) remained unknown. This propensity score matched analysis from a high-volume single center reveals that compared with the VATS approach, RATS had similar long-term survival outcomes in stage I NSCLC with radiologic solid tumors, and was associated with more lymph node dissection.

oncology
The chemical anatomy of extra-cellular water: contribution of erythrocyte water.

H. Swan,A. W. Nelson

1973-09-01

Abstract:
Robot-assisted Bronchial Sleeve Left Upper Lobectomy for Locally Advanced Bronchopulmonary Squamous Cell Carcinoma after Neoadjuvant Chemotherapy: a Case Report

Xianfei Zhang,Dingpei Han,Jie Xiang,Kai Chen,Hecheng Li

DOI: https://doi.org/10.21037/jovs-19-182

2022-01-01

Journal of Visualized Surgery

Abstract:For patients with central bronchopulmonary malignancies, sleeve lobectomy serves as an alternative to pneumonectomy. In recent years, robotic-assisted technique has been innovatively developed and applied in sleeve lobectomy. Here, we introduce a patient treated with chemotherapy who received robotic bronchial sleeve lobectomy without pulmonary vessel anastomosis in our department. The patient was a 53-year-old male smoker, who had suffered irritable cough for 6 months. During surgery we found that the tumor was tightly adhered to the pulmonary artery. Robotic scissors were used to separate the tumor from the surface of the pulmonary artery. Finally, the tumor was removed along with the relevant bronchus, and the pulmonary artery remained intact. The tumor margins were verified as negative by fast frozen pathology during the procedure. This experience in our department demonstrates the advantages of robotassisted bronchial lobectomy in preserving pulmonary vessels in patients with pulmonary arterial adventitia involvement.
A Systematic Review And Meta-Analysis Of Thoracoscopic Versus Thoracotomy Sleeve Lobectomy

Yifan Zhong,Yang Wang,Xuefei Hu,Gege Wang,Yunlang She,Jiajun Deng,Lei Zhang,Qiao Peng,Yuming Zhu,Gening Jiang,Minglei Yang,Dong Xie,Chang Chen

DOI: https://doi.org/10.21037/jtd-20-1855

2020-01-01

Journal of Thoracic Disease

Abstract:Background: Operative safety and oncologic adequacy of thoracoscopic sleeve lobectomy remain controversial. As such, the purpose of this meta-analysis was to evaluate evidence comparing thoracoscopy and thoracotomy in sleeve lobectomy for centrally located non-small cell lung cancer (NSCLC).Methods: Electronic searches of PubMed and Web of Science databases were undertaken from inception to March 2020. Comparative studies about thoracoscopic and thoracotomy sleeve lobectomy, with evaluation for perioperative outcomes and oncological results were identified. The following outcomes were measured in this meta-analysis: operating time, blood loss, numbers of lymph node, postoperative hospital stay, chest drainage time, postoperative complication rate, mortality, overall survival (OS). The standardized difference (SMD), relative risk (RR) and hazard ratio (HR) with 95% confidence intervals (CI) were pooled using Stata software.Results: Six studies generating 281 thoracoscopy and 369 thoracotomy cases were finally included. There was no significant difference in intraoperative blood loss, number of resected lymph nodes, chest drainage time, postoperative complication rate and mortality between two groups. However, thoracoscopic sleeve lobectomy was associated with longer operation time (SMD 0.59, 95% CI: 0.14 to 1.03, P=0.010). And shorter postoperative hospital stays (SMD -0.24, 95% CI: -0.51 to 0.03, P=0.078) were observed in the thoracoscopy group with marginal significance. Furthermore, sleeve lobectomy via thoracoscopy could achieve comparable OS compared to that via thoracotomy (HR 0.69, 95% CI: 0.38 to 1.00; P<0.001). In addition, there were no evident publication bias in all observational outcomes.Conclusions: Current evidence suggests that thoracoscopic sleeve lobectomy is a safe and efficient surgical procedure for centrally located NSCLC, with comparable perioperative outcomes and equivalent oncological results compared to thoracotomy sleeve lobectomy.
Robotic‐assisted Thoracoscopic Surgery Improves Perioperative Outcomes in Overweight and Obese Patients with Non–small‐cell Lung Cancer Undergoing Lobectomy: A Propensity Score Matching Analysis

Rongyang Li,Zheng Ma,Yanzhi Li,Chenghao Qu,Jianhao Qiu,Yu Zhang,Kun Wang,Weiming Yue,Hui Tian

DOI: https://doi.org/10.1111/1759-7714.14597

IF: 3.223

2022-01-01

Thoracic Cancer

Abstract:Abstract Background The effectiveness of robotic‐assisted lobectomy (RAL) for patients with non–small‐cell lung cancer (NSCLC) has not been fully evaluated. Methods This retrospective study compared the perioperative outcomes of NSCLC patients who underwent RAL and video‐assisted lobectomy (VAL) using propensity score matching (PSM) analysis. Subgroup analyses were then performed. Results A total of 822 NSCLC patients (359 RAL cases and 463 VAL cases) were included, and there were 292 patients in each group after PSM. Compared with the VAL group, the RAL group had a significantly higher number of lymph nodes (LNs) harvested (10 vs. 8, p < 0.001) and more LN stations examined (6 vs. 5, p < 0.001). The operative duration (95 minutes vs. 115 minutes, p < 0.001) and intraoperative estimated blood loss (65 mL vs. 80 mL, p < 0.001) were significantly reduced, and the drainage volume on postoperative day (POD) 1 (240 mL vs. 200 mL, p < 0.001) and hospitalization costs (¥81084.96 vs. ¥66142.55, p < 0.001) were significantly higher in the RAL group. Subgroup analysis indicated that the incidence of postoperative complications (17.9% vs. 26.7%, p = 0.042) was significantly reduced in the RAL group for overweight and obese patients (body mass index [BMI] ≥24 kg/m2), which became insignificant in the BMI < 24 kg/m2 subgroup (31.0% vs. 24.8%, p = 0.307). Conclusion RAL might have potential advantages in terms of lymph node assessment, reducing intraoperative blood loss, and shortening operation duration. Overweight and obese patients could benefit more from RAL because of reduced risk of postoperative complications.
Video-assisted Thoracoscopic Surgery Sleeve Lobectomy with Bronchoplasty

Yun Li,Jun Wang

DOI: https://doi.org/10.1007/s00268-013-2032-7

IF: 3.282

2013-01-01

World Journal of Surgery

Abstract:OBJECTIVES:We summarize our experiences of video-assisted thoracoscopic surgery (VATS) sleeve lobectomy with bronchoplasty for non-small-cell lung cancer and discuss the indications and technical details of the operation.METHODS:From September 2011 to December 2012, 15 patients underwent VATS sleeve lobectomy with bronchoplasty at our institution (right upper lobe 10, right middle and lower lobes 1, left lower lobe 2 and left upper lobe 2), with mediastinal lymphadenectomy. Three incisions were utilized. The utility incision was made at the fourth intercostal space, anterior axillary line. Simple continuous and simple interrupted suturing of the membranous and cartilaginous portions of the bronchus were performed for the anastomosis.RESULTS:All procedures were uneventful, with a median operative time of 165 min, a median bronchial anastomosis time of 44 min and a median blood loss of 150 ml. There were no conversions to thoracotomy. There were 14 squamous carcinomas and 1 adenocarcinoma. All patients recovered well, and 1 experienced a minor complication. The median duration of chest tube drainage was 5.4 days, and the median length of hospital stay was 7 days. All patients were followed postoperatively for a range of 1-16 months without tumour recurrence.CONCLUSIONS:VATS sleeve lobectomy with bronchoplasty is safe and effective. The utility incision placed at the fourth intercostal space, anterior axillary line, is convenient for the anastomosis, and the suturing technique is expeditious and secure. Preserving the azygos vein does not compromise exposure for the anastomosis. This technique is very suitable for centrally located lung cancers <3 cm in diameter, particularly when the cancers are located within the brachial lumen.
Comparing Robotic, Thoracoscopic, and Open Segmentectomy: A National Cancer Database Analysis

Raul Caso,Thomas J Watson,Eshetu Tefera,Robert Cerfolio,Abbas E Abbas,John F Lazar,Marc Margolis,Ann E Hwalek,Puja Gaur Khaitan,Thomas J. Watson,Abbas E. Abbas,John F. Lazar,Ann E. Hwalek

DOI: https://doi.org/10.1016/j.jss.2024.01.028

IF: 2.417

2024-04-01

Journal of Surgical Research

Abstract:INTRODUCTION: Minimally invasive approaches to lung resection have become widely acceptable and more recently, segmentectomy has demonstrated equivalent oncologic outcomes when compared to lobectomy for early-stage non-small cell lung cancer (NSCLC). However, studies comparing outcomes following segmentectomy by different surgical approaches are lacking. Our objective was to investigate the outcomes of patients undergoing robotic, video-assisted thoracoscopic surgery (VATS), or open segmentectomy for NSCLC using the National Cancer Database.METHODS: NSCLC patients with clinical stage I who underwent segmentectomy from 2010 to 2016 were identified. After propensity-score matching (1:4:1), multivariate logistic regression analyses were performed to determine predictors of 30-d readmissions, 90-d mortality, and overall survival.RESULTS: 22,792 patients met study inclusion. After matching, approaches included robotic (n = 2493; 17%), VATS (n = 9972; 66%), and open (n = 2493; 17%). An open approach was associated with higher 30-d readmissions (7% open versus 5.5% VATS versus 5.6% robot, P = 0.033) and 90-d mortality (4.4% open versus 2.2% VATS versus 2.5% robot, P < 0.001). A robotic approach was associated with improved 5-y survival (50% open versus 58% VATS versus 63% robot, P < 0.001).CONCLUSIONS: For patients with clinical stage I NSCLC undergoing segmentectomy, compared to the open approach, a VATS approach was associated with lower 30-d readmission and 90-d mortality. A robotic approach was associated with improved 5-y survival compared to open and VATS approaches when matched. Additional studies are necessary to determine if unrecognized covariates contribute to these differences.

surgery
Robotic Sleeve Resection of the Airway: Outcomes and Technical Conduct Using Video Vignettes

Travis C Geraci,Dana Ferrari-Light,Simeng Wang,Brian Mitzman,Stephanie H Chang,Amie Kent,Harvey I Pass,Costas Bizekis,Michael Zervos,Robert J Cerfolio

DOI: https://doi.org/10.1016/j.athoracsur.2020.01.077

Abstract:Background: Our objectives are to report our outcomes and to demonstrate our evolving technique for robotic sleeve resection of the airway, with or without lobectomy, using video vignettes. Methods: We retrospectively reviewed a single-surgeon prospective database from October 2010 to October 2019. Results: Over 9 years, of 5573 operations 1951 were planned for a robotic approach. There were 755 robotic lobectomies and 306 robotic segmentectomies, and 23 consecutive patients were scheduled for elective completely portal, robotic sleeve resection. Sleeve lobectomy was performed in 18 patients: 10 right upper lobe, 6 left upper lobe, and 2 right lower lobe. Two patients had mainstem bronchus resections and 2 underwent right bronchus intermedius resections that preserved the entire lung. One patient had a robotic pneumonectomy. One operation was converted to open thoracotomy because of concern for anastomotic tension in a patient who received neoadjuvant therapy. All patients had an R0 resection. In the last 10 operations we modified our airway anastomosis, using a running self-locking absorbable suture. The median length of hospital stay was 3 days (range, 1-11), with no 30- or 90-day mortalities. Within a median follow-up of 18 months, there were no anastomotic strictures and no recurrent cancers. Conclusions: Our early and midterm results show that a completely portal robotic sleeve resection is safe and oncologically effective. Trhe technical aspects of a robotic sleeve resection of the airway are demonstrated using video vignettes.
A middle lobe sparing sleeve resection versus bilobectomy for right lower central non-small cell lung cancer: a retrospective propensity score matched cohort study

Jiongjie Wang,Jichao Guo,Haizhan Shi,Xiangru Chen,Wenxin He,Zhixin Li

DOI: https://doi.org/10.1186/s13019-024-02744-5

2024-04-16

Journal of Cardiothoracic Surgery

Abstract:Abstract Objectives The right lower sleeve lobectomy is a rarely performed major lung resection.This study aims to evaluate the safety and effectiveness of this procedure by comparing to right lower bilobectomy in non-small cell lung cancer patients. Methods We retrospectively reviewed a prospective database of non-small cell lung cancer patients who underwent right lower sleeve lobectomy (group S) or right lower bilobectomy (group B) from January 2014 to January 2020 in Shanghai Pulmonary Hospital. Propensity score matching method was applied to balance confounders between the two groups, resulting in 41 matched pairs.The analysis was performed to compare perioperative outcomes, long-term survival, and postoperative pulmonary volume between the two groups. Results No significant differences in the characteristics were observed between the two matched groups.Major postoperative complications developed in 31.7% of the patients in group B and 12.1% of the patients in group S ( P = 0.032).Intervention rate for surgical residual cavity in group B is significantly higher than those patients in group S(21.9%vs7.3%, p = 0.037).The postoperative right lateral and overall lung volume in group S were both significantly larger than that in group B ( P = 0.026, P = 0.001,respectively). Conclusions Compared to bi-lobectomy, a middle lobe sparing sleeve resection obtains a less prevalence of major complications, smaller postoperative residual air space and similar long-term survival for selected central right lower NSCLC patients.

surgery,cardiac & cardiovascular systems
Genome-wide detection and analysis of recent segmental duplications within mammalian organisms.

J. A. Bailey,E. Eichler

DOI: https://doi.org/10.1101/SQB.2003.68.115

Cold Spring Harbor Symposia on Quantitative Biology

Abstract:
Fresh thinking about fresh whole blood

J. Hess

DOI: https://doi.org/10.1111/j.1537-2995.2010.02854.x

2011-01-01

Transfusion

Abstract:T his issue of TRANSFUSION contains an article by Jobes and colleagues that investigates how long the platelets (PLTs) in cold-stored whole blood function in PLT function tests. However, they pose the question as “How long are the PLTs in fresh whole blood fresh?” It is a strangely worded question, and it does not allay concerns about the relevance of the in vitro data to clinical practice. Fresh, however defined, is not necessarily better than appropriately stored, and PLTs removed from the circulation cannot contribute to “integrated coagulation function.” Jobes and colleagues are from the Children’s Hospital of Philadelphia (CHOP) where for many years they have used “fresh whole blood” collected by the American Red Cross in their pediatric cardiac surgery program. They say they use this product because it provides superior hemostasis. The blood is collected from volunteers who meet all of the conventional donor criteria, is fully tested for infectious diseases, and is cooled to 6°C within 8 hours of collection as required by law. The whole blood is typically used within 2 to 5 days or made into leukoreduced red blood cells (RBCs) if not needed for the surgery or discarded. They report that in vitro PLT function is retained in cold-stored whole blood for at least 2 weeks. Others have found the same thing. But for 45 years, we have known that the PLTs in cold-stored whole blood do not stop the bleeding in acute leukemia; for 40 years, we have known that coldstored PLTs do not circulate; and for 8 years we have known why cold-stored PLTs are removed from the circulation. When the National Cancer Institute (NCI) began treating acute leukemia in the late 1950s, they rapidly discovered that bleeding and infection were the major consequences of myeloablative chemotherapy. The article by Gaydos and colleagues showing that bleeding was rare at PLT counts above 20 ¥ 10/L, and incidentally creating a transfusion trigger at the value that lasted for decades, came from this NCI group. PLTs from the cold-stored units of whole blood did not stop the bleeding in these patients. Treatment of an acute bleed required the rapid collection of several units of warm fresh whole blood and the separation of PLTs from the PLT-rich plasma removed from the tops of blood bottles. This was possible but logistically difficult in the days when the only infectious disease test was for syphilis. Tibor Greenwalt, chair of the National Academy of Science’s Committee on Blood Transfusion, and colleagues described this situation in a committee report in JAMA in 1966. Three years later, Murphy and Gardner showed that infused cold-stored PLTs did not persist in the circulation, and Murphy spent his career developing better methods of PLT separation, warm storage with agitation, and oxygen-permeable bags that enable current 5to 7-day PLT storage around the world. Finally, in 2003, Karin Hoffmeister and colleagues described the aggregation of glycoprotein Ib on the surface of cold-stored PLTs and their removal by galactose receptors on liver cells. So what is going on at CHOP? Clearly, they are exposing children to the added immunologic risks of nonleukoreduced whole blood for a potential coagulation benefit in which most of us do not believe. They justify this on the basis of a study their institution performed and published 18 years ago, which attempted to randomize infants and children undergoing open heart surgery to warm fresh whole blood, cold-stored fresh whole blood, and blood components. However, randomization did not work because the sickest and smallest children were frequently taken to surgery on short notice with available bank blood. Nevertheless, the study was evaluated as if it was randomized, and the relatively poorer outcomes in these sickest and smallest children made the use of banked blood in these children look like the least successful option. However, the study only achieved borderline significance and only that by failing to correct for multiple comparisons. Now that warm fresh whole blood is no longer available because of the need for more time-consuming infectious disease testing, they presumably view coldstored “fresh whole blood” as the next best available option. But even the cold-stored whole blood available today is stored longer because of the time required for nucleic acid testing than that used at the time of the study. Variations in the use of blood products in cardiac surgery are well-reported phenomena. Surgenor and colleagues described large differences in the use of blood in coronary artery bypass surgery in five US university hospitals in the late 1990s. Blood use in the most similar cohorts varied from 33% to 90% between the hospitals and was not related to patient mix or individual surgeon preference. The authors concluded, “We believe that the effects of the specific hospital on blood transfusion practice are the result of deeply ingrained institutional differences in training and hierarchical practices within the hospitals.” Andreasen and colleagues reported a similar difference of 30% to 62% transfusion rates among five hospitals performing bypass surgery in Denmark, and a TRANSFUSION 2011;51:5-7.
Robotic lobectomy for non-small cell lung cancer

Brian E Louie

DOI: https://doi.org/10.1007/s13193-013-0212-4

Abstract:Over the last 5 years, there has been a tremendous increase in the interest in and use of robotics in thoracic surgery. The focus of this review is on the use of robotics for pulmonary lobectomy, which is being approached with 3 or 4 arm techniques. Early experiences suggest that the learning curve is approximately 20 cases for most surgeons but could be shortened with previous advanced thoracoscopic skills. Robotic lobectomy is feasible and safe in limited reports from experienced centers. Operative and clinical outcomes favor robotic lobectomy over open and appear to be similar to VATS. Limited data on oncologic effectiveness and survival suggest that robotics is similar to VATS. Widespread adoption and integration into practice will require future research efforts to prove oncologic and survival benefits in concert with cost effectiveness evaluation.
Deformation in the lowermost mantle beneath Australia from observations and models of seismic anisotropy

N. Creasy,M. Long,H. Ford

DOI: https://doi.org/10.1002/2016JB013901

2017-07-01

Abstract:Observations of seismic anisotropy near the core‐mantle boundary may yield constraints on patterns of lowermost mantle flow. We examine seismic anisotropy in the lowermost mantle beneath Australia, bounded by the African and Pacific Large Low Shear Velocity Provinces. We combined measurements of differential splitting of SKS‐SKKS and S‐ScS phases sampling our study region over a range of azimuths, using data from 10 long‐running seismic stations. Observations reveal complex and laterally heterogeneous anisotropy in the lowermost mantle. We identified two subregions for which we have robust measurements of D″‐associated splitting for a range of ray propagation directions and applied a forward modeling strategy to understand which anisotropic scenarios are consistent with the observations. We tested a variety of elastic tensors and orientations, including single‐crystal elasticity of lowermost mantle minerals (bridgmanite, postperovskite, and ferropericlase), tensors based on texture modeling in postperovskite aggregates, elasticity predicted from deformation experiments on polycrystalline MgO aggregates, and tensors that approximate the shape preferred orientation of partial melt. We find that postperovskite scenarios are more consistently able to reproduce the observations. Beneath New Zealand, the observations suggest a nearly horizontal [100] axis orientation with an azimuth that agrees well with the horizontal flow direction predicted by previous mantle flow models. Our modeling results further suggest that dominant slip on the (010) plane in postperovskite aggregates provides a good fit to the data but the solution is nonunique. Our results have implications for the mechanisms of deformation and anisotropy in the lowermost mantle and for the patterns of mantle flow.

[Muscular contraction and metabolic conditions].

Early Outcomes of Robotic Versus Thoracoscopic Segmentectomy for Early-Stage Lung Cancer: A Multi-Institutional Propensity Score-Matched Analysis

Comparison of Robotic and Video-Assisted Thoracic Surgery for Lung Cancer: a Propensity-Matched Analysis.

Perioperative Comparison of Video-Assisted Thoracic Surgery and Open Lobectomy for Pt1-Stage Non-Small Cell Lung Cancer Patients in China: a Multi-Center Propensity Score-Matched Analysis.

Comparing the Efficacy of Video-Assisted Thoracoscopic Surgery and Open Thoracotomy in Sleeve Lobectomy for the Treatment of Central-Type Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis.

[Short-term and long-term survival in sleeve lobectomy by video-assisted thoracic surgery versus thoracotomy basing on the propensity score matching]

Comparison of Sleeve Lobectomy for Lung Cancer Using Mini-Thoracotomy and an Optimized Robot-Assisted Technique

Initial Experience of Robotic Sleeve Resection for Lung Cancer Patients

Comparison of long-term survival between robotic and video-assisted lobectomy for stage I NSCLC with radiologic solid tumors:A Propensity Score Matching Study

The chemical anatomy of extra-cellular water: contribution of erythrocyte water.

Robot-assisted Bronchial Sleeve Left Upper Lobectomy for Locally Advanced Bronchopulmonary Squamous Cell Carcinoma after Neoadjuvant Chemotherapy: a Case Report

A Systematic Review And Meta-Analysis Of Thoracoscopic Versus Thoracotomy Sleeve Lobectomy

Robotic‐assisted Thoracoscopic Surgery Improves Perioperative Outcomes in Overweight and Obese Patients with Non–small‐cell Lung Cancer Undergoing Lobectomy: A Propensity Score Matching Analysis

Video-assisted Thoracoscopic Surgery Sleeve Lobectomy with Bronchoplasty

Comparing Robotic, Thoracoscopic, and Open Segmentectomy: A National Cancer Database Analysis

Robotic Sleeve Resection of the Airway: Outcomes and Technical Conduct Using Video Vignettes

A middle lobe sparing sleeve resection versus bilobectomy for right lower central non-small cell lung cancer: a retrospective propensity score matched cohort study

Genome-wide detection and analysis of recent segmental duplications within mammalian organisms.

Fresh thinking about fresh whole blood

Robotic lobectomy for non-small cell lung cancer

Deformation in the lowermost mantle beneath Australia from observations and models of seismic anisotropy